Nutritional High International Inc.(CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) (the “Company” or “Nutritional High”) is pleased to comment on President Trump’s favourable comments in support of a federally-led approach to cannabis regulation and the recent appointment of former House Speaker John Boehner to the advisory board of a private U.S. cannabis company.
Nutritional High International Inc.(CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) (the “Company” or “Nutritional High”) is pleased to comment on President Trump’s favourable comments in support of a federally-led approach to cannabis regulation and the recent appointment of former House Speaker John Boehner to the advisory board of a private U.S. cannabis company. The Company believes these developments provide significant support to the U.S. cannabis market and signal potential positive developments ahead for the regulatory status of cannabis in the U.S.
On April 13, 2018, the Washington Post reported that President Trump and Colorado Senator Cory Gardner reached an understanding that the marijuana industry in Colorado will not be subject to interference from the federal government and that the Department of Justice’s recession of the Cole memo will not impact Colorado’s legal marijuana industry. In addition, Senator Gardner reported that during their conversations, President Trump asserted his belief that cannabis regulations are a states’ rights issue that should be determined without intervention from the federal government. Furthermore, President Trump provided assurances that he will support a federalism-based legislative solution to prevent future federal involvement in state-level cannabis regulation.
Two days’ prior, on April 11, 2018 it was reported that former Speaker of the House John Boehner was joining the advisory board of a private U.S cannabis company. Mr. Boehner was previously a staunch opponent of cannabis legalization in the U.S., but in a statement announcing his appointment he alluded to an evolution in his views based on a range of factors, including shifting public perception and the potential efficacy of cannabis use for treatment of medical ailments.
Jim Frazier, CEO of Nutritional High, commented, “We are very excited about both Speaker Boehner’s joining a U.S.-based cannabis company and President Trump’s recent favourable stance to cannabis regulation. We believe these developments serve as significant indications of changing perceptions towards cannabis in the U.S., and we look forward to the continuing evolution of the industry. Operating in a more favourable regulatory environment will bolster our operational and strategic objectives and should drive further value to our shareholders going forward.”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing premium and consistently dosed products in the cannabis-infused products industry, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+or visit www.nutritionalhigh.com.
For further information, please contact:
Chairman of the Board
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Risks that may have an impact on the ability for these events to be achieved include completion of due diligence, negotiation of definitive agreements and receipt of applicable approvals. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. Some of the risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information expressed in this press release include, but are not limited to: obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, the uncertainty of existing protection from U.S. federal or other prosecution, regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, market and general economic conditions of the cannabis sector or otherwise.